EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
$0.6002per EA

Strength

200; 300 mg/1; mg/1

Manufacturer

Cipla USA Inc.

NDC

69097020902

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

10/23/2024

Approval Type

Generic (ANDA)

FDA Application

ANDA090958

On Market Since

3/30/2021

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-4.2%

5Y

N/A

All

-49.1%